LYMPHOCYTE PERCENTAGE INCREASED side effect
What is LYMPHOCYTE PERCENTAGE INCREASED ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
LYMPHOCYTE PERCENTAGE INCREASED and Recently Reported Side Effects
LYMPHOCYTE PERCENTAGE INCREASED and 15 most Active Side Effect polls
LYMPHOCYTE PERCENTAGE INCREASED and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with LYMPHOCYTE PERCENTAGE INCREASED
AROMASIN CLOZARIL GEMTUZUMAB GLYCOPYRROLATE LAMISIL PRAVASTATIN TYSABRIPravastatin Side Effects Report #5660423-X
Consumer or non-health professional from GREECE reported PRAVASTATIN problem on Feb 25, 2008. Male patient, 60 years of age, was diagnosed with hypercholesterolaemia and was treated with PRAVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, lymphocyte percentage increased, neutrophil percentage decreased, pleural effusion, . PRAVASTATIN dosage: 40 MG; QD, 40 MG; QD. Patient recovered.
Tysabri Side Effects Report #5586068-8
TYSABRI problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 27, 2007. Male patient, 51 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: lung infiltration, lymphocyte percentage increased, neutropenic sepsis, white blood cell count decreased, . TYSABRI dosage: 300 MG;QM;IV. During the same period patient was treated with NEURONTIN, MIRAPEX, LAMICTAL, PROVIGIL, ZOCOR, FLUVOXAMINE MALEATE, VIAGRA. Patient was hospitalized. Patient recovered.
Glycopyrrolate Side Effects Report #5578846-6
Physician from UNITED STATES reported GLYCOPYRROLATE problem on Dec 20, 2007. Female patient, 18 years of age, weighting 53.00 lb, was diagnosed with drooling and was treated with GLYCOPYRROLATE. After drug was administered, patient experienced the following problems/side effects: discomfort, lymphocyte percentage increased, oxygen saturation decreased, pyrexia, restlessness, sinus tachycardia, urinary tract infection enterococcal, urinary tract infection staphylococcal, white blood cell count increased, . GLYCOPYRROLATE dosage: 12.5 ML TID, PO. During the same period patient was treated with DANTROLENE, ZANTAC, CLONIDINE, BACLOFEN, REGLAN, CARNITINE, FOSAMAX, MIRALAX. Patient was hospitalized. Patient recovered.
Aromasin Side Effects Report #5706769-8
AROMASIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 15, 2008. Female patient, weighting 131.0 lb, was treated with AROMASIN. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, lymphocyte percentage increased, monocyte percentage increased, neutropenia, white blood cell count decreased, . AROMASIN dosage: 147.5 MG. Patient was hospitalized. Patient recovered.
Clozaril Side Effects Report #5361542-8
Physician from UNITED KINGDOM reported CLOZARIL problem on June 11, 2007. Male patient, 66 years of age, was diagnosed with schizophrenia, depression and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: lymphocyte count decreased, lymphocyte percentage increased, . CLOZARIL dosage: 200MG MANE AND 250MG NOCTE. During the same period patient was treated with VENLAFAXINE. Patient recovered.
Lamisil Side Effects Report #5743396-0
LAMISIL problem was reported by a Pharmacist from UNITED STATES on May 16, 2008. Female patient, 68 years of age, weighting 185.0 lb, was diagnosed with tinea capitis and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, condition aggravated, lymphocyte percentage increased, neutropenia, white blood cell count decreased, . LAMISIL dosage: unknown. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #5258283-4
Physician from BELGIUM reported GEMTUZUMAB OZOGAMICIN problem on Mar 02, 2007. Female patient, 44 years of age, weighting 102.5 lb, was diagnosed with antifungal prophylaxis and was treated with GEMTUZUMAB OZOGAMICIN. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, coma, lymphocyte percentage increased, neutrophil percentage decreased, platelet count decreased, white blood cell count decreased, . GEMTUZUMAB OZOGAMICIN dosage: unknown. During the same period patient was treated with TPN ELECTROLYTES IN PLASTIC CONTAINER, DIFLUCAN, LARGACTIL, IDARUBICIN, CYTARABINE. Patient died on 04/16/2006.